Prognostic factors, treatment, and survival in cutaneous pleomorphic sarcoma
- 1 August 2020
- journal article
- research article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 83 (2), 388-396
- https://doi.org/10.1016/j.jaad.2018.08.054
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Management of Unusual Cutaneous Malignancies: Atypical Fibroxanthoma, Malignant Fibrous Histiocytoma, Sebaceous Carcinoma, Extramammary Paget DiseaseDermatologic Clinics, 2011
- Malignant fibrous histiocytoma of the head and neck regionHead & Neck, 2011
- Establishment of a new human pleomorphic malignant fibrous histiocytoma cell line, FU-MFH-2: molecular cytogenetic characterization by multicolor fluorescence in situ hybridization and comparative genomic hybridizationJournal of Experimental & Clinical Cancer Research, 2010
- Malignant fibrous histiocytoma: Outcome of tumours in the head and neck compared with those in the trunk and extremitiesBritish Journal of Oral and Maxillofacial Surgery, 2006
- Malignant fibrous histiocytoma of the extremities and trunk: An institutional reviewSurgery, 2004
- Locoregional Treatment for Adult Soft Tissue Sarcomas of the Head and NeckThe Cancer Journal, 2003
- Discriminant analysis of prognostic factors for malignant fibrous histiocytoma in soft tissueJournal of Orthopaedic Science, 2001
- Immunoexpression of Ultraviolet Photoproducts and p53 Mutation Analysis in Atypical Fibroxanthoma and Superficial Malignant Fibrous HistiocytomaLaboratory Investigation, 2001
- Prognostic factors in 227 patients with malignant fibrous histiocytomaCancer, 1992
- Malignant Fibrous Histiocytoma of the Head and Neck: A Report of 12 CasesJAMA Otolaryngology–Head & Neck Surgery, 1988